Potential Drug Molecules
This page provides information about the potential drug molecules for Mucormycosis.
Protein Name | Uniprot ID | Drug | DrugBank ID | Action | Use | |
---|---|---|---|---|---|---|
CYP51 | A0A2U8U7V7_RHIOR | Miconazole | DB01110 | Inhibitor | Used to treat fungal infections affecting the vagina, mouth and skin, including candidiasis. | |
CYP51 | A0A2U8U7V7_RHIOR | Oxiconazole | DB00239 | Inhibitor | Used in the treatment of various skin infections such as athlete's foot, jock itch and ringworm. | |
CYP51 | A0A2U8U7V7_RHIOR | Fluconazole | DB00196 | Inhibitor | Used for the treatment of both systemic and superficial fungal infections in a variety of tissues. | |
CYP51 | A0A2U8U7V7_RHIOR | Bifonazole | DB04794 | Inhibitor | Used to treat fungal skin infections, such as dermatomycosis. | |
CYP51 | A0A2U8U7V7_RHIOR | Sertaconazole | DB01153 | Inhibitor | Used in the treatment of interdigital tinea pedis in immunocompetent patients.. | |
CYP51 | A0A2U8U7V7_RHIOR | Clotrimazole | DB00257 | Antagonist/inhibitor | Used for the treatment of a wide variety of dermatophyte infections and candidiasis. | |
CYP51 | A0A2U8U7V7_RHIOR | Econazole | DB01127 | Antagonist | Used to treat tinea pedis, tinea cruris, tinea corporis, cutaneous candidiasis and tinea versicolor. | |
CYP51 | A0A2U8U7V7_RHIOR | Posaconazole | DB01263 | Antagonist | Used to treat invasive infections by Candida species and Aspergillus species in severely immunocompromised patients. | |
CYP51 | A0A2U8U7V7_RHIOR | Terconazole | DB00251 | Antagonist | Used in the treatment of vulvovaginal candidiasis. | |
CYP51 | A0A2U8U7V7_RHIOR | Tioconazole | DB01007 | Antagonist | Used to treat vulvovaginal candidiasis.. | |
CYP51 | A0A2U8U7V7_RHIOR | Voriconazole | DB00582 | Antagonist/inhibitor | Used to treat fungal infections. | |
CYP51 | A0A2U8U7V7_RHIOR | Luliconazole | DB08933 | Inhibitor | Used to treat fungal infections. | |
CYP51 | A0A2U8U7V7_RHIOR | Oteseconazole | DB13055 | Inhibitor | Used to prevent recurrent vulvovaginal candidiasis in females who are not of reproductive potential. | |
CYP51 | A0A2U8U7V7_RHIOR | Itraconazole | DB01167 | Inhibitor | Used for the treatment of various fungal infections in immunocompromised and non-immunocompromised patients, such as pulmonary and extrapulmonary blastomycosis, histoplasmosis, and onychomycosis. | |
CYP51 | A0A2U8U7V7_RHIOR | Ketoconazole | DB01026 | Inhibitor | Used to treat seborrheic dermatitis and fungal skin infections. | |
CYP51 | A0A2U8U7V7_RHIOR | Efinaconazole | DB09040 | Inhibitor | Used to treat onychomycosis, a fungal infection of the nail. | |
CYP51 | A0A2U8U7V7_RHIOR | Isavuconazole | DB11633 | Inhibitor | Used for treatment of invasive aspergillosis and mucormycosis | |
CYP51 | A0A2U8U7V7_RHIOR | Sulconazole | DB06820 | Inhibitor | Used for the treatment of tinea cruris, tinea corporis, and tinea versicolor caused by susceptible fungal strains. | |
ARF | I1C4D3_RHIO9 | Chlortetracycline | DB09093 | Inhibitor | Used for veterinary purposes. | |
ARF | I1C4D3_RHIO9 | Artenimol | DB11638 | Ligand | Used in the treatment of uncomplicated Plasmodium falciparum infections | |
DHD | I1CS69_RHIO9 | Glycine | DB00145 | Substrate | Used as a component of total parenteral nutrition and is also used as irrigation during surgery. | |
CaN | I1CTP1_RHIO9 | Voclosporin | DB11693 | Inhibitor | Used in the treatment of lupus nephritis (LN) in patients diagnosed with systemic lupus erythematosus (SLE). | |
CaN | I1CTP1_RHIO9 | Cyclosporine | DB00091 | Inhibitor | Used in organ and bone marrow transplants as well as inflammatory conditions such as ulcerative colitis, rheumatoid arthritis, and atopic dermatitis. |